NeuroMetrix to Present at Canaccord Genuity Growth Conference WALTHAM, Mass., Aug 02, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N.
NeuroMetrix, Inc. Announces Date for 2011 Second Quarter Financial Results Conference Call WALTHAM, Mass., Jul 21, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 second quarter financial results before the opening of the market on July 28, 2011.
NeuroMetrix Reports Successful Marketing Launch of NC-stat(R)|DPNCheck(TM) at the American Diabetes Association 71st Scientific Sessions WALTHAM, Mass., Jul 06, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it met its planned marketing launch date for NC-stat ®
NeuroMetrix To Launch Product Targeted at Diabetes Market at the American Diabetes Association 71st Scientific Sessions WALTHAM, Mass., Jun 20, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it expects to meet its planned launch date for its latest product, NC-stat ®
Nipro Diagnostics and NeuroMetrix Announce Diabetes Focused Collaboration for the Retail Medical Clinic Market WALTHAM, Mass. & FT LAUDERDALE, Fla., Jun 15, 2011 (BUSINESS WIRE) -- Nipro Diagnostics, Inc. and NeuroMetrix, Inc. (Nasdaq: NURO) today announced their collaboration to evaluate
NeuroMetrix, Inc. Announces Date for 2011 First Quarter Financial Results Conference Call WALTHAM, Mass., Apr 21, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 first quarter financial results before the opening of the market on April 28, 2011.
NeuroMetrix to Preview New Product Targeted at Diabetes Market at the American Association of Clinical Endocrinologists Annual Meeting WALTHAM, Mass., Apr 13, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will preview its newest product - NC-stat ® | DPNCheck
